MDAI - NASDAQ

Spectral AI, Inc.

MDAI·NASDAQ

$2.01

+0.75%

HealthcareMedical - Devices

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$63.97M

EPS-0.2900

P/E Ratio-6.93

Earnings Date08/11/2026

21.41M

Assets

77%

3Y+14.0%

5Y+12881.0%

10Y+12881.0%

27.13M

Total Liabilities

40%

3Y+304.0%

5Y+19201.0%

10Y+19201.0%

-5.73M

Total Equity

-21%

3Y-148.0%

5Y-23644.0%

10Y-23644.0%

Spectral AI, Inc. Funding & Solvency Profile

MDAI · NASDAQ

Current Assets

Cash & Cash Equivalents15.39M

Net Receivables1.27M

Inventory838.00K

Other Current Assets1.95M

Total Current Assets19 M

Non-Current Assets

Property, Plant & Equipment1.67M

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets287.00K

Total Non-Current Assets2 M

Total Assets

21.41M

Financial Health Analysis

Current Ratio

0.94x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Working Capital

-1173000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

91% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Spectral AI, Inc. Balance Sheet

MDAI • NASDAQ

Spectral AI, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	15.4M	5.2M	4.8M	14.2M	16.1M	0.0
Cash & Short-Term Investments	15.4M	5.2M	4.8M	14.2M	16.1M	0.0
Net Receivables	1.3M	2.5M	2.3M	2.9M	1.5M	0.0
Accounts Receivables	1.3M	2.5M	2.3M	2.3M	1.4M	0.0
Other Receivables	0.0	0.0	0.0	618K	71K	0.0
Inventory	838K	425K	230K	0.0	0.0	0.0
Prepaids	0.0	1.3M	1.5M	331K	313.1K	0.0
Other Current Assets	2M	746K	1.1M	270K	526.9K	0.0
Total Current Assets	19.5M	10.1M	9.9M	17.7M	18.5M	0.0
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.7M	2M	790K	1M	32K	0.0
Long-Term Investments	0.0	0.0	0.0	4.6M	253M	0.0
Other Non-Current Assets	287K	0.0	0.0	-4.6M	-253M	164.9K
Total Non-Current Assets	2M	2M	790K	1M	72K	164.9K
Total Assets	21.4M	12.1M	10.7M	18.7M	18.5M	164.9K
LIABILITIES
CURRENT LIABILITIES
Total Payables	3M	4M	2.8M	2.9M	1.7M	0.0
Accounts Payable	3M	4M	2.7M	2.8M	1.4M	0.0
Other Payables	0.0	0.0	107K	110K	246K	0.0
Accrued Expenses	0.0	3M	4.2M	2.5M	1.4M	0.0
Short Term Debt	3.6M	2.8M	436K	175K	583K	40K
Capital Lease Obligations (Current)	0.0	201K	853K	680K	0.0	0.0
Tax Payables	0.0	188K	107K	110K	246K	0.0
Deferred Revenue	154K	960K	2.3M	0.0	23K	0.0
Other Current Liabilities	13.9M	6.6M	1.8M	129K	1.1M	100.6K
Total Current Liabilities	20.6M	17.6M	12.4M	6.4M	4.8M	140.6K
NON-CURRENT LIABILITIES
Long Term Debt	6.5M	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	0.0	0.0	0.0	0.0	19M	0.0
Total Non-Current Liabilities	6.5M	1.7M	0.0	346K	19M	0.0
Other Liabilities	0.0	0.0	0.0	0.0	-19M	0.0
Capital Lease Obligations	0.0	1.9M	853K	1M	0.0	0.0
Total Liabilities	27.1M	19.3M	12.4M	6.7M	4.8M	140.6K
SHAREHOLDERS' EQUITY
Common Stock	3K	2K	2K	1K	135K	575.0
Additional Paid-In Capital	50M	40.8M	31.1M	23.9M	22.6M	0.0
Retained Earnings	-55.8M	-48.1M	-32.8M	-11.9M	-9M	-675.0
Accumulated Other Comprehensive Income/Loss	40K	3K	12K	0.0	0.0	0.0
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	24.4K
Total Stockholders' Equity	-5.7M	-7.3M	-1.7M	12M	13.8M	24.3K
Total Equity	-5.7M	-7.3M	-1.7M	12M	13.8M	24.3K
SUMMARY
Total Liabilities & Equity	21.4M	12.1M	10.7M	18.7M	18.5M	164.9K
Total Investments	0.0	0.0	0.0	4.6M	253M	0.0
Total Debt	10.1M	4.7M	1.3M	1.2M	583K	40K
Net Debt	-5.3M	-467K	-3.5M	-13M	-15.5M	40K
Shares Outstanding	26,710,659	26,710,659	26,710,659	26,710,659	26,710,659	26,710,659

SEC Filings

MDAI - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 01, 2026	May 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 26, 2026	May 26, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 13, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 22, 2026	April 17, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 16, 2026	May 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 08, 2026	April 03, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 25, 2026	March 24, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 25, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 20, 2026	March 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 10, 2026	February 09, 2026	2026	View Filing

Showing 1 to 10 of 108 filings

Related Guides

Blog Categories

Continue your MDAI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.